Aphria Inc. (APHA)
(Delayed Data from NYSE)
$6.94 USD
-0.19 (-2.66%)
Updated May 3, 2019 04:02 PM ET
After-Market: $7.00 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.94 USD
-0.19 (-2.66%)
Updated May 3, 2019 04:02 PM ET
After-Market: $7.00 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Marijuana Stocks To Consider Before Celebrating 420
by Daniel Laboe
In the wake of this marijuana holiday's inevitable festivities, the US house of representatives passed the SAFE Banking Act, which would give US marijuana companies access to funding from federally insured banks.
Aphria Inc. (APHA) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Aphria Inc. (APHA) delivered earnings and revenue surprises of -300.00% and -9.84%, respectively, for the quarter ended February 2021. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for Aphria (APHA) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Aphria (APHA) stock based on the movements in the options market lately.
These 5 Toxic Stocks Could Hurt Your Portfolio
by Rimmi Singhi
Keep your portfolio protected from toxic stocks like MELI, APHA, NFE, HHC and IDCC.
Aphria Inc. (APHA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Aphria Inc. (APHA) closed at $16.27, marking a +0.49% move from the previous day.
New Strong Sell Stocks for April 8th
by Zacks Equity Research
APHA, CS, and ENV have been added to the Zacks Rank #5 (Strong Sell) List on April 8, 2021
Best Performing ETFs of Q1 2021
by Neena Mishra
We highlight top performing ETF areas of the first quarter
Aphria Inc. (APHA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Aphria Inc. (APHA) closed at $18.12 in the latest trading session, marking a -1.36% move from the prior day.
Inside the Top-Performing ETFs of Q1
by Sweta Killa
Amplify Seymour Cannabis ETF (CNBS) topped the list of the best-performing ETFs of February with impressive returns of about 60%.
Aphria Inc. (APHA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Aphria Inc. (APHA) closed at $19.34, marking a +0.78% move from the previous day.
Aphria Inc. (APHA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Aphria Inc. (APHA) closed at $20 in the latest trading session, marking a +0.7% move from the prior day.
Aphria Inc. (APHA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Aphria Inc. (APHA) closed the most recent trading day at $18.95, moving +1.01% from the previous trading session.
Should You Invest in Marijuana Stocks & ETFs Now?
by Neena Mishra
CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.
Tilray (TLRY) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports fourth-quarter 2020 results.
Is the Options Market Predicting a Spike in Aphria (APHA) Stock?
by Zacks Equity Research
Investors need to pay close attention to Aphria (APHA) stock based on the movements in the options market lately.
Cannabis Stocks Rise on Hopes of Federal Legalization in US
by Zacks Equity Research
Cannabis stocks seem poised to gain on hopes of removal of the federal ban on cannabis products under the new administration.
New Strong Sell Stocks for February 10th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Cannabis ETFs Spike on Jazz-GW Pharma Deal
by Sweta Killa
Jazz Pharmaceuticals (JAZZ) agreed to buy cannabinoid drug company GW Pharmaceuticals (GWPH) for $7.2 billion in cash and stock that has strengthened the bullish case for the cannabis industry.
Cannabis ETF Tops in January: 5 Stocks That Led the Way
by Sweta Killa
Inside the top performing stocks in the top ETF of January.
Aphria Inc. (APHA) Reports Break-Even Earnings for Q2
by Zacks Equity Research
Aphria Inc. (APHA) delivered earnings and revenue surprises of 100.00% and 2.12%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?
Aphria (APHA) Looks Good: Stock Adds 6% in Session
by Zacks Equity Research
Aphria (APHA) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Aphria Inc. (APHA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Aphria Inc. (APHA) closed at $8.57, marking a -0.23% move from the previous day.
Will Aphria Inc. (APHA) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Aphria Inc. (APHA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aphria Inc. (APHA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
by Zacks Equity Research
Aphria Inc. (APHA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aphria Inc. (APHA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Aphria Inc. (APHA) closed at $6.92 in the latest trading session, marking a -1.98% move from the prior day.